United Therapeutics Aktie

Kaufen
Verkaufen
343,40 EUR +1,70 EUR +0,50 %
359,76 USD +2,59 USD +0,73 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 15,36 Mrd. EUR

KGV 11,10 Div. Rendite 0,00%

WKN 923818

ISIN US91307C1027

Symbol UTHR


United Therapeutics Aktie Analyse

12.10.18 United Therapeutics Buy Standpoint Research
22.02.18 United Therapeutics Underweight Barclays Capital
27.12.17 United Therapeutics Outperform Wedbush Morgan Securities Inc.
27.04.17 United Therapeutics Outperform Wedbush Morgan Securities Inc.
30.03.17 United Therapeutics Sell UBS AG
19.01.17 United Therapeutics Hold Standpoint Research
15.06.16 United Therapeutics Neutral H.C. Wainwright & Co.
11.04.16 United Therapeutics Sector Perform RBC Capital Markets
28.03.16 United Therapeutics Outperform Wedbush Morgan Securities Inc.
02.03.16 United Therapeutics Outperform Wedbush Morgan Securities Inc.
31.07.15 United Therapeutics Buy Argus Research Company
29.07.15 United Therapeutics Sector Perform RBC Capital Markets
27.05.15 United Therapeutics Buy Argus Research Company
29.04.15 United Therapeutics Sector Perform RBC Capital Markets
12.03.15 United Therapeutics Buy Argus Research Company
04.03.15 United Therapeutics Hold Standpoint Research
26.02.15 United Therapeutics Buy H.C. Wainwright & Co.
03.11.14 United Therapeutics Hold Argus Research Company
15.10.14 United Therapeutics Buy Standpoint Research
25.07.12 United Therapeutics sector perform RBC Capital Markets
26.03.12 United Therapeutics sector perform RBC Capital Markets
26.08.11 United Therapeutics buy Goldman Sachs Group Inc.
26.08.11 United Therapeutics outperform Oppenheimer & Co. Inc.
14.06.11 United Therapeutics sector perform RBC Capital Markets
07.06.11 United Therapeutics buy Citigroup Corp.
23.02.11 United Therapeutics buy Stifel, Nicolaus & Co., Inc.
16.02.11 United Therapeutics neutral Wedbush Morgan Securities Inc.
15.02.11 United Therapeutics neutral Wedbush Morgan Securities Inc.
08.02.11 United Therapeutics buy Goldman Sachs Group Inc.
24.01.11 United Therapeutics outperform Oppenheimer & Co. Inc.
27.10.10 United Therapeutics neutral Wedbush Morgan Securities Inc.
23.04.10 United Therapeutics halten Wedbush Morgan Securities Inc.
03.08.09 United Therapeutics neutral JP Morgan Chase & Co.
31.07.09 United Therapeutics neutral Wedbush Morgan Securities Inc.
27.07.09 United Therapeutics outperform Wedbush Morgan Securities Inc.
19.05.09 United Therapeutics buy Soleil Securities Group, Inc.
20.04.09 United Therapeutics equal weight Barclays Capital
17.03.09 United Therapeutics buy Jefferies & Company Inc.
17.03.09 United Therapeutics buy Ladenburg Thalmann & Co. Inc.
17.03.09 United Therapeutics strong buy Wedbush Morgan Securities Inc.
12.03.09 United Therapeutics neutral FTN Midwest Securities Corp.
19.11.08 United Therapeutics neutral Piper Jaffray & Co.
18.11.08 United Therapeutics hold Deutsche Bank AG
18.11.08 United Therapeutics buy Brean Murray, Carret & Co., LLC
17.10.08 United Therapeutics buy Brean Murray, Carret & Co., LLC
24.09.08 United Therapeutics buy Jefferies & Company Inc.
19.09.08 United Therapeutics buy Stanford Financial Group, Inc.
12.08.08 United Therapeutics sell Piper Jaffray & Co.
01.08.08 United Therapeutics buy Ladenburg Thalmann & Co. Inc.
01.08.08 United Therapeutics market outperform Rodman & Renshaw, LLC